At Inbeeo, Market Access truly is our passion and we love to share our thoughts on the latest developments in the field through our blog and also in publications. Should you have a topic that you would value our thoughts on then please do get in touch – we would love to hear from you.

In France, the value equation may change (a little)

A milestone event took place in France on July 10, when France's healthcare industry strategic council CSIS met an agreement with the French Government to strengthen France’s appeal for HealthCare industries. The Government announced a long series of measures, some of them will impact the market access and pricing of pharmaceuticals and other healthcare products.

Six Drugs that Cost a Medicare Part D Beneficiary more than $10,000 a Year

No one will argue that Medicare Part D met a genuine need at its inception in the mid-2000s - offering Medicare beneficiaries an affordable voluntary health insurance plan that would cover their outpatient prescription needs. Fast forward 10 years. Has Part D met its objective? In terms of the availability of a wide range of plans at an affordable premium in all parts of the nation, yes, definitely. In terms of actual payments made to beneficiaries, this is a question mark.

Healthcare Appraisal: The Evolution

The Health Foundation and ICHOM are among the many stakeholders calling for an evolution of how we look at value in healthcare. Here are four trends…
All articles loaded
No more articles to load